Related Experiment Video
Updated: Jun 2, 2025
Author Spotlight: Developing a Rat Model for Pouchitis Research and Treatment
Published on: May 31, 2024
The effects of hyperbaric treatment on perianal fistula activity in patients with Crohn's disease
Grażyna Piotrowicz1, Jacek Kot2,3, Andrzej Babicki4
1Department of Gastroenterology, Self-Dependent Health Care Unit of Ministry of Interior and Administration, Gdansk, Poland.
Insights
Hyperbaric oxygen therapy (HBOT) significantly improved Crohn's disease activity and perianal fistula symptoms. Patients experienced over 50% remission rates, with benefits sustained long-term.
Area of Science:
- Gastroenterology
- Inflammatory Bowel Disease Research
- Oxygen Therapy Applications
Background:
- Crohn's disease is a chronic gastrointestinal inflammatory disorder.
- Perianal fistulas are a challenging complication of Crohn's disease.
Purpose of the Study:
- To evaluate the efficacy of hyperbaric oxygen therapy (HBOT) as an adjunct treatment for perianal fistulas in Crohn's disease patients.
- To assess HBOT's impact on disease activity and inflammatory markers.
Main Methods:
- Patients with Crohn's disease-associated perianal fistulas received HBOT alongside standard therapy.
- Disease activity was measured using Crohn's Disease Activity Index (CDAI), Simple Endoscopic Score for Crohn's Disease (SESCD), and Perianal Disease Activity Index (PDAI).
- Laboratory markers including faecal calprotectin and C-reactive protein (CRP) were monitored.
Main Results:
- HBOT combined with conventional therapy led to significant clinical improvements.
- An 81.8% improvement in CDAI scores and a 54.5% clinical remission rate (SESCD, PDAI) were observed.
- Positive effects on SESCD, PDAI, and faecal calprotectin persisted for 6 weeks and showed sustained benefits at 9 months.
Conclusions:
- HBOT is a potential therapeutic adjunct for managing complex Crohn's disease with perianal fistulas.
- It offers significant clinical improvements and high remission rates, especially for treatment-resistant cases.
- HBOT shows promise for improving outcomes in this patient population.
Introduction:
Crohn's disease is a chronic, complex inflammatory disorder of the gastrointestinal tract. Among its most challenging complications are perianal fistulas.
Aim:
This study aims to explore the efficacy of hyperbaric oxygen therapy (HBOT) in reducing the activity of perianal fistulas in Crohn's disease patients.
Material And Methods:
This study enrolled patients diagnosed with Crohn's disease-associated perianal fistulas, with a disease duration of at least 3 years. Participants underwent HBOT in conjunction with standard medical therapy. The therapeutic effects were assessed at predetermined intervals using the Crohn's Disease Activity Index (CDAI), and laboratory parameters including faecal calprotectin levels, C-reactive protein (CRP) activity, serum iron concentration, and peripheral blood haemoglobin levels. Additionally, the Simple Endoscopic Score for Crohn's Disease (SESCD) and the Perianal Disease Activity Index (PDAI) were employed for evaluation.
Results:
The adjunctive use of HBOT with conventional therapy yielded significant clinical improvements in patients with Crohn's disease complicated by perianal fistulas. This was shown by an 81.8% improvement in CDAI scores and a 54.5% clinical remission rate, as determined by SESCD and PDAI. Notably, the beneficial effects of HBOT on SESCD, PDAI, and faecal calprotectin levels were statistically significant and persisted for 6 weeks post-HBOT, with sustained improvements observed in a follow-up assessment approximately 9 months after treatment.
Conclusions:
The findings of this study suggest that HBOT may be a viable therapeutic adjunct in the management of complex cases of Crohn's disease, particularly those with recurrent symptoms and limited responsiveness to conventional treatments. HBOT demonstrated potential in improving clinical outcomes and achieving remission rates exceeding 50%, indicating its promise as a treatment modality in this patient population.
Related Concept Videos
01:21Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
01:30Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
01:17Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...